Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Genser

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
World Journal of Gastroenterology|March 22, 2007
Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver diseaseAndre Castro Lyra, Milena Botelho Pereira Soares, Luiz Flavio Maia da Silva, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 7, 2026
A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkersCaterina M Leone, Giuseppe di Pietro, Giulia di Stefano, et al.
Iscience|October 23, 2023
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trialVincent Rathkolb, Marianna T Traugott, Andreas Heinzel, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Nature|December 11, 2012
Seventy-five genetic loci influencing the human red blood cellPim van der Harst, Weihua Zhang, Irene Mateo Leach, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
World Journal of Gastroenterology|March 22, 2007
Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver diseaseAndre Castro Lyra, Milena Botelho Pereira Soares, Luiz Flavio Maia da Silva, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 7, 2026
A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkersCaterina M Leone, Giuseppe di Pietro, Giulia di Stefano, et al.
Iscience|October 23, 2023
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trialVincent Rathkolb, Marianna T Traugott, Andreas Heinzel, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Nature|December 11, 2012
Seventy-five genetic loci influencing the human red blood cellPim van der Harst, Weihua Zhang, Irene Mateo Leach, et al.
Pageof 8